7.5 tirzepatide to semaglutide vs Tirzepatide: Which GLP-1 Wins for Weight Loss? Tirzepatide vs. Semaglutide for Weight

The Non-Peptide GLP-1 Receptor Agonist WB4-24 Blocks Inflammatory Nociception by Stimulating -Endorphin Release From Spinal Microglia

The medication also produced a mean 9.4% weight loss and improvements in blood pressure (3.3 mm Hg systolic), inflammatory markers (37.8% high-sensitivity CRP), and lipid profilesall achieved on top of existing treatments

Against Phentermine/Topiramate, Tirzepatide demonstrated a significant association only with dry eye disease (HR 0.29, 95% CI: 0.150.57, p = 1.3 10 4 ), while other outcomes including cataracts (HR 0.76, 95% CI: 0.381.52, p = 0.433) and oculomotor binocular dysfunction (HR 0.63, 95% CI: 0.341.16, p = 0.134) showed non-significant trends

You have 28 days of usable solution when stored properly in the refrigerator

The New England journal of medicine, 393(18), 17961806

Periodicum Biologorum 81:13335.[Web of Science ] , [Google Scholar])